ND-108E

N/A

Report date: 2023/12/07 12:02:53
NME

Base Information

Drug NameND-108E
Drug Alias NameND108END-108EHACD-ND108E
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAmyloid beta-protein precursor inhibitorsMitochondrial proteins stimulantsMicrotubule-associated protein tau inhibitors
TargetsAmyloid beta-protein precursorMitochondrial proteinsMicrotubule-associated protein tau
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHoly Stone Healthcare Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHoly Stone Healthcare Co Ltd
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A